Nippon Universal Of Japan To Add Sales Staff For Parent Zydus Generics
This article was originally published in PharmAsia News
Executive Summary
Japan's Nippon Universal Pharmaceutical, a subsidiary of India's Zydus, plans an expansion within Japan, increasing its medical representative staff from 30 to 50. Although Zydus specializes in generics, the new staff members are to handle new drugs that result from a partnership between Zydus and Eli Lilly of the United States. Nippon Universal plans to introduce as many as six generics to have a portfolio of more than 30 drugs by the end of this year. Zydus also is considering handling generics made by other drug makers in addition to its own line. (Click here for more - a subscription may be required